Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-21 Sale |
2021-07-23 4:29 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
146,511 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-09-12 Option Award |
2024-09-16 9:05 pm |
N/A 2034-09-11 |
Zenas BioPharma Inc. | ZBIO | ORLOFF JOHN J Director |
18,500 | $0 | 18,500 (Direct) |
View |
Ownership |
2024-09-12 9:43 pm |
N/A 2032-03-10 |
Zenas BioPharma Inc. | ZBIO | ORLOFF JOHN J Director |
0 | $0 | 40,307 (Direct) |
View |
| 2021-07-14 Option Award |
2021-07-16 4:48 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
60,144 | $0 | 146,511 (Direct) |
View |
| 2021-06-08 Tax Withholding |
2021-06-09 4:53 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
1,957 | $177 | 86,367 (Direct) |
View |
| 2021-02-28 Option Award |
2021-03-02 5:50 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
24,473 | $0 | 88,324 (Direct) |
View |
| 2020-12-16 Tax Withholding |
2020-12-18 5:06 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
21,395 | $157.96 | 63,851 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-18 5:06 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
40 | $93.53 | 63,851 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 5:06 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
40,677 | $0 | 63,851 (Direct) |
View |
| 2020-06-08 Tax Withholding |
2020-06-09 4:59 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
2,784 | $114.61 | 44,529 (Direct) |
View |